iVascularU

Executive Summary

iVascularU is a vertically integrated Spanish medical device company focused on advanced catheter-based therapies for cardiovascular and neurovascular diseases. Founded in 2010 and headquartered in Barcelona, the company develops and commercializes drug-eluting stents, drug-coated balloons, and stroke intervention systems. Its product portfolio targets coronary, peripheral, and neurovascular indications, leveraging proprietary polymer science and in-house manufacturing to ensure quality and cost control. While primarily serving European and select international markets, iVascular has been gaining traction through competitive pricing and clinical data supporting its devices. The company's vertical integration and focus on innovation differentiate it from larger competitors. Key growth drivers include expanding its neurovascular stroke product line, seeking regulatory approvals in new geographies (e.g., FDA clearance for the US market), and launching next-generation drug-coated balloons. However, risks include intense competition from established players, regulatory hurdles, and reliance on a narrow product range. iVascular's disciplined approach and strategic partnerships position it for steady growth, though near-term catalysts remain tied to clinical milestones and market expansion.

Upcoming Catalysts (preview)

• Q3 2026FDA approval for neurovascular stroke device50% success
• Q3 2026Positive 12-month data from next-generation drug-coated balloon trial70% success
• Q3 2026Partnership or distribution agreement for US market entry40% success